Bouchey Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bouchey Financial Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,086	Closed	-$213K	–	114
2023 Q1	$213K	Buy	3,086 +157	+5%	+$11.1K	0.03%	95
2022 Q4	$211K	Hold	2,929	–	–	0.03%	87
2022 Q3	$208K	Buy	+2,929	New	+$212K	0.03%	82
2022 Q2	–	Sell	-2,929	Closed	-$214K	–	86
2022 Q1	$214K	Buy	+2,929	New	+$197K	0.03%	92

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bouchey Financial Group's BMY Position: Q2 2023 in Review

Bouchey Financial Group sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 3,086 shares — an estimated $213K sold.

Bouchey Financial Group first reported a position in BMY in Q1 2022 and held it in 4 quarters. The position peaked at $214K in Q1 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Bouchey Financial Group reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Bouchey Financial Group sold 3,086 Bristol-Myers Squibb shares in Q2 2023, an estimated $213K.
Bouchey Financial Group first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 4 quarters.
Bouchey Financial Group's Bristol-Myers Squibb position peaked at $214K in Q1 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Bouchey Financial Group's 13F filing for Q2 2023, filed 13 Jul 2023.